Effect of Vitamin K Epoxide Reductase Complex 1 Polymorphism on Warfarin Dose Requirement among Patients in Tertiary Care Hospital

BACKGROUND: Warfarin, anticoagulant is used for thromboembolic disorders. Inter-individual variation in clinical response to warfarin is due to various factors, including polymorphism of Vitamin K epoxide reductase complex 1 (VKORC1)-1639G>A. The aim of our study was to evaluate the effect of VKO...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeregowda, Sahana Hadihalli, Krishnaswamy, Bhuvana, Balakrishna, Sharath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289213/
https://www.ncbi.nlm.nih.gov/pubmed/32566525
http://dx.doi.org/10.4103/ijabmr.IJABMR_341_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289213/
https://www.ncbi.nlm.nih.gov/pubmed/32566525
http://dx.doi.org/10.4103/ijabmr.IJABMR_341_18

Ejemplares similares